本页面由Tiger Trade Technology Pte. Ltd.提供服务

C4 Therapeutics, Inc.

3.06
-0.1000-3.16%
盘后:3.060.00000.00%19:56 EDT
成交量:150.04万
成交额:465.64万
市值:3.76亿
市盈率:-3.37
高:3.30
开:3.16
低:3.05
收:3.16
52周最高:5.17
52周最低:1.69
股本:1.23亿
流通股本:9,451.50万
量比:0.67
换手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-0.9085
每股收益(LYR):-1.2666
净资产收益率:-48.14%
总资产收益率:-19.25%
市净率:1.52
市盈率(LYR):-2.42

数据加载中...

2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/08

重要事件披露

8-K - Current report
2022/03/16

重要事件披露

8-K - Current report
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/21

重要事件披露

8-K/A [Amend] - Current report
2022/01/10

重要事件披露

8-K - Current report
2021/11/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/15

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/12

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/11

重要事件披露

8-K - Current report
2021/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]